Emergent BioSolutions (EBS) Asset Writedowns and Impairment (2010 - 2026)
Emergent BioSolutions (EBS) posted Asset Writedowns and Impairment of $191.3 million for Q2 2026, up 1468.03% on a QoQ basis from $12.2 million in Q4 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Asset Writedowns and Impairment for 13 years, with the latest figure at $191.3 million in Q2 2026.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $191.3 million in Q2 2026; TTM through Jun 2026 was $203.5 million, a 648.16% increase from a year earlier, with the FY2025 full-year figure at $12.2 million, down 55.15% from the prior year.
- Asset Writedowns and Impairment was $191.3 million for Q2 2026 at Emergent BioSolutions, up from $12.2 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $306.7 million in Q2 2023, with the low at $12.2 million in Q4 2025.
- Average Asset Writedowns and Impairment over 4 years is $134.4 million, with a median of $109.2 million recorded in 2024.
- The largest YoY upside for Asset Writedowns and Impairment was 91.13% in 2024 against a maximum downside of 91.13% in 2024.
- Over 4 years, Asset Writedowns and Impairment stood at $306.7 million in 2023, then sank by 91.13% to $27.2 million in 2024, then slumped by 55.15% to $12.2 million in 2025, then soared by 1468.03% to $191.3 million in 2026.
- The last three Asset Writedowns and Impairment figures came in at $191.3 million (Q2 2026), $12.2 million (Q4 2025), and $27.2 million (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 191.30 Mn |
| Dec 31, 2025 | 12.20 Mn |
| Jun 30, 2024 | 27.20 Mn |
| Jun 30, 2023 | 306.70 Mn |
| Dec 31, 2019 | 12.00 Mn |
| Jun 30, 2018 | 229,000.00 |
| Mar 31, 2018 | 34,000.00 |
| Dec 31, 2016 | 1.85 Mn |
| Sep 30, 2016 | 2.64 Mn |
| Sep 30, 2015 | 9.83 Mn |
| Mar 31, 2014 | 1.83 Mn |
| Dec 31, 2013 | 1.17 Mn |
| Mar 31, 2012 | 9.60 Mn |
| Dec 31, 2011 | 300,000.00 |
| Dec 31, 2010 | 189,000.00 |
API Access
Emergent BioSolutions Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();